News Release
- November 8, 2021
- Notice of Establishment of Medical Device Sales Subsidiary in the Socialist Republic of Vietnam (200KB)
- November 5, 2021
- Joint Establishment of a CTA Dialyzer Production Plant with Toyobo —Strengthen the production system to meet growing global demand— (179KB)
- November 4, 2021
- Notice of Establishment of Overseas Offices in China (153KB)
- September 9, 2021
- Publishment of NIPRO CORPORATION Social Finance Framework (496KB)
Issuance of Second Opinion by R&I (693KB) - September 6, 2021
- Notice of Establishment of Overseas Offices in China (294KB)
- August 18, 2021
- Notice of Results of Human Coronavirus (OC43) Inactivation Performance Test by Humidification Using Ionless™ Hypochlorous Acid Water CL Fine® (818KB)
- May 26, 2021
- Notice of Contract Manufacturing Agreement for Domestic Supply of AstraZeneca COVID-19 vaccine “Vaxzevria™ intramuscular injection” (160KB)
- May 17, 2021
- Acquisition of Shares of a Pharmaceutical Glass Container Manufacturing and Sales Company by a Nipro Overseas Subsidiary (354KB)
- April 26, 2021
- Acquisition of Shares of Changsha Bairong Dialysis Center and Shenyang Yizhiyuan Dialysis Center in China (192KB)
- April 6, 2021
- Notice of Establishment of an Overseas Office in China (301KB)
- January 5, 2021
- New Year's Message from President Sano of Nipro Corporation Delivered January 5, 2021 (257KB)